Evidence map›Paper›PMID 39506942›Full record

ReviewHeliyon2024

Update on antimicrobial resistance in Somalia: Current status, challenges, opportunities, and future perspectives.

Shafie Abdulkadir Hassan, Ahmed Mohamed Dirie, Nur Rashid Ahmed, Abdifetah Ibrahim Omar

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shafie Abdulkadir HassanDepartment of Medical Laboratory Sciences, Faculty of Medicine and Health Sciences, Jamhuriya University of Science and Technology, Mogadishu, Somalia.
Ahmed Mohamed DirieFaculty of Health Sciences, Salaam University, Mogadishu, Somalia.
Nur Rashid AhmedJamhuriya Research Center, Jamhuriya University of Science and Technology, Mogadishu, Somalia.
Abdifetah Ibrahim OmarJamhuriya Research Center, Jamhuriya University of Science and Technology, Mogadishu, Somalia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a critical global health challenge, and Somalia is no exception. This update examines the current status of AMR in Somalia, highlighting the prevalent patterns of resistance, contributing factors, and significant health impacts. Despite limited surveillance data, evidence suggests rising resistance to key antibiotics, exacerbated by inadequate healthcare infrastructure, overuse of antimicrobials, and lack of regulatory oversight. The review identifies key challenges, including insufficient diagnostic capabilities, poor infection control practices, and a need for robust stewardship programs. Opportunities for addressing AMR in Somalia are discussed, including strengthening surveillance systems, improving healthcare access, and fostering international collaboration. Future perspectives emphasize the importance of integrating AMR strategies into broader health policies, enhancing public awareness, and investing in research to develop new treatments and prevention methods. Addressing these issues is crucial for mitigating the impact of AMR and improving health outcomes in Somalia.

Indexed as

Antimicrobial resistanceChallengesOne healthOpportunitiesSomalia

Identifiers

PMID39506942
PMCPMC11538744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.